Mallorie B. Heneghan

516 total citations
19 papers, 343 citations indexed

About

Mallorie B. Heneghan is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Mallorie B. Heneghan has authored 19 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Mallorie B. Heneghan's work include Childhood Cancer Survivors' Quality of Life (6 papers), Adolescent and Pediatric Healthcare (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Mallorie B. Heneghan is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (6 papers), Adolescent and Pediatric Healthcare (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Mallorie B. Heneghan collaborates with scholars based in United States, Switzerland and Canada. Mallorie B. Heneghan's co-authors include Sherif M. Badawy, Nicole M. Alberts, Alexandra Gilbert, Mark C. Udey, Jeffrey C. Hanson, Lino Tessarollo, Keisuke Nagao, María I. Morasso, Susan Mackem and Alix E. Seif and has published in prestigious journals such as Blood, PLoS ONE and Journal of Medical Internet Research.

In The Last Decade

Mallorie B. Heneghan

15 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mallorie B. Heneghan United States 9 102 71 64 59 49 19 343
Maureen Haugen United States 10 89 0.9× 28 0.4× 55 0.9× 33 0.6× 28 0.6× 14 309
Jennifer Devlen United States 10 114 1.1× 63 0.9× 60 0.9× 164 2.8× 13 0.3× 20 532
Andrea Schumacher Germany 11 132 1.3× 33 0.5× 87 1.4× 139 2.4× 34 0.7× 34 449
Carlos Melero Moreno Spain 17 36 0.4× 67 0.9× 34 0.5× 46 0.8× 77 1.6× 55 808
Megan L. Curran United States 13 57 0.6× 44 0.6× 143 2.2× 15 0.3× 56 1.1× 33 537
Danielle Blanch Hartigan United States 3 313 3.1× 62 0.9× 206 3.2× 85 1.4× 24 0.5× 4 489
Morgan Johnson United States 13 19 0.2× 63 0.9× 52 0.8× 73 1.2× 40 0.8× 51 444
Ting Guan United States 13 106 1.0× 119 1.7× 133 2.1× 131 2.2× 53 1.1× 50 508
Nagavalli Somasundaram Singapore 11 33 0.3× 51 0.7× 86 1.3× 145 2.5× 26 0.5× 37 357
A Tsourapas United Kingdom 9 88 0.9× 92 1.3× 148 2.3× 16 0.3× 20 0.4× 14 725

Countries citing papers authored by Mallorie B. Heneghan

Since Specialization
Citations

This map shows the geographic impact of Mallorie B. Heneghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mallorie B. Heneghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mallorie B. Heneghan more than expected).

Fields of papers citing papers by Mallorie B. Heneghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mallorie B. Heneghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mallorie B. Heneghan. The network helps show where Mallorie B. Heneghan may publish in the future.

Co-authorship network of co-authors of Mallorie B. Heneghan

This figure shows the co-authorship network connecting the top 25 collaborators of Mallorie B. Heneghan. A scholar is included among the top collaborators of Mallorie B. Heneghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mallorie B. Heneghan. Mallorie B. Heneghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yang, Mi-Ra, Maureen Haugen, Elaine Morgan, et al.. (2025). Adherence to 6‐Mercaptopurine (6‐MP) and Habit Strength in Pediatric Acute Lymphoblastic Leukemia (ALL). European Journal Of Haematology. 114(5). 864–871.
2.
Heneghan, Mallorie B., Susan K. Parsons, Frank G. Keller, et al.. (2024). Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma. JCO Oncology Practice. 21(4). 526–534. 3 indexed citations
3.
Heneghan, Mallorie B., Jennifer A. Belsky, Sarah A. Milgrom, & Christopher J. Forlenza. (2024). The pediatric approach to Hodgkin lymphoma. Seminars in Hematology. 61(4). 245–252. 2 indexed citations
4.
Heneghan, Mallorie B., Sharon M. Castellino, & Lindsay A. Thompson. (2024). What Is Childhood Lymphoma?. JAMA Pediatrics. 178(11). 1234–1234.
5.
Heneghan, Mallorie B., et al.. (2024). Use of Patient-Centered Technology and Digital Interventions in Pediatric and Adult Patients with Hematologic Malignancies. Current Hematologic Malignancy Reports. 19(4). 153–162.
6.
King, Kathryn, et al.. (2023). Barriers to medication adherence in sickle cell disease: A comprehensive theory‐based evaluation using the COM‐B model. Pediatric Blood & Cancer. 70(9). e30440–e30440. 3 indexed citations
7.
8.
Wilson, Christina, et al.. (2022). How technology can improve communication and health outcomes in patients with advanced cancer: an integrative review. Supportive Care in Cancer. 30(8). 6525–6543. 10 indexed citations
9.
Heneghan, Mallorie B., Leonardo Barrera, Maureen Haugen, et al.. (2021). Access to Technology and Preferences for an mHealth Intervention to Promote Medication Adherence in Pediatric Acute Lymphoblastic Leukemia: Approach Leveraging Behavior Change Techniques. Journal of Medical Internet Research. 23(2). e24893–e24893. 20 indexed citations
10.
11.
Badawy, Sherif M., et al.. (2020). Habit Strength, Medication Adherence, and Habit-Based Mobile Health Interventions Across Chronic Medical Conditions: Systematic Review. Journal of Medical Internet Research. 22(4). e17883–e17883. 47 indexed citations
12.
Heneghan, Mallorie B., Leonardo Barrera, Maureen Haugen, et al.. (2020). Applying the COM‐B model to patient‐reported barriers to medication adherence in pediatric acute lymphoblastic leukemia. Pediatric Blood & Cancer. 67(5). e28216–e28216. 20 indexed citations
13.
Gilbert, Alexandra, et al.. (2019). eHealth and mHealth interventions in pediatric cancer: A systematic review of interventions across the cancer continuum. Psycho-Oncology. 29(1). 17–37. 114 indexed citations
14.
Heneghan, Mallorie B., et al.. (2018). No Cause for Alarm: Decreasing Inappropriate Pulse Oximetry Use in Bronchiolitis. Hospital Pediatrics. 8(2). 109–111. 4 indexed citations
15.
Desai, Ami V., Mallorie B. Heneghan, Nancy Bunin, et al.. (2016). Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma. Bone Marrow Transplantation. 51(9). 1204–1210. 32 indexed citations
16.
Heneghan, Mallorie B., Susan R. Rheingold, Yimei Li, et al.. (2016). Treatment of Osteonecrosis in Children and Adolescents With Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 16(4). 223–229.e2. 15 indexed citations
17.
Oshrine, Benjamin, Mallorie B. Heneghan, Gerald Wertheim, et al.. (2014). Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor. Cancer Genetics. 207(4). 153–159. 20 indexed citations
18.
19.
Nagao, Keisuke, Jianjian Zhu, Mallorie B. Heneghan, et al.. (2009). Abnormal Placental Development and Early Embryonic Lethality in EpCAM-Null Mice. PLoS ONE. 4(12). e8543–e8543. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maureen Haugen Breakdown of academic impact, for papers by Jennifer Devlen Breakdown of academic impact, for papers by Andrea Schumacher Breakdown of academic impact, for papers by Carlos Melero Moreno Breakdown of academic impact, for papers by Megan L. Curran Breakdown of academic impact, for papers by Danielle Blanch Hartigan Breakdown of academic impact, for papers by Morgan Johnson Breakdown of academic impact, for papers by Ting Guan Breakdown of academic impact, for papers by Nagavalli Somasundaram Breakdown of academic impact, for papers by A Tsourapas
Rankless by CCL
2026